These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 4470109

  • 1. [Biological exploration of Paget's disease (author's transl)].
    Nagant de Deuxchaisnes C, Rombouts-Lindemans C.
    J Belge Rhumatol Med Phys; 1974; 29(5-6):243-92. PubMed ID: 4470109
    [No Abstract] [Full Text] [Related]

  • 2. [Bone mineral measurement in Paget's disease].
    Nuti R, Vattimo A.
    Boll Soc Ital Biol Sper; 1978 Jan 30; 54(2):141-5. PubMed ID: 737061
    [No Abstract] [Full Text] [Related]

  • 3. [Biological exploration of Paget's disease (author's transl)].
    Nagant de Deuxchaisnes C, Rombouts-Lindemans C.
    Acta Orthop Belg; 1974 Jan 30; 40(4):375-424. PubMed ID: 4620051
    [No Abstract] [Full Text] [Related]

  • 4. Effects of prolonged thyrocalcitonin administration on Paget's disease of bone.
    Haddad JG, Birge SJ, Avioli LV.
    N Engl J Med; 1970 Sep 10; 283(11):549-55. PubMed ID: 5450609
    [No Abstract] [Full Text] [Related]

  • 5. [Hydroxyproline excretion in the urine in Paget's osteodystrophia deformans. Comparative clinical, morphological and biochemical studies].
    Raab W, Czitober H.
    Wien Klin Wochenschr; 1967 Feb 03; 79(5):91-3. PubMed ID: 5591364
    [No Abstract] [Full Text] [Related]

  • 6. [The treatment of Paget's disease using salmon thyrocalcitonin. 8 cases (author's transl)].
    Deplante JP, Daumont A, Bouvier M, Lejeune E.
    Nouv Presse Med; 1978 Nov 25; 7(41):3753-6. PubMed ID: 733525
    [Abstract] [Full Text] [Related]

  • 7. [Decrease of the coefficient of intestinal calcium absorption with normal blood levels of 1,25-dihydroxyvitamin D and decreasing levels of 24,25-dihydroxyvitamin D in Paget's disease of bone].
    Traba ML, Climent P, Rapado A, de la Piedra C, Díaz Curiel M.
    Rev Clin Esp; 1986 Nov 25; 179(8):401-3. PubMed ID: 3494277
    [No Abstract] [Full Text] [Related]

  • 8. Biochemical markers of bone turnover in Paget's disease of bone.
    Eastell R.
    Bone; 1999 May 25; 24(5 Suppl):49S-50S. PubMed ID: 10321928
    [No Abstract] [Full Text] [Related]

  • 9. [Biological and isotope explorations in Paget's disease of bone].
    Dell'Anno R, Eisinger J, Recordier AM.
    Rhumatologie; 1971 Apr 25; 23(4):119-39. PubMed ID: 4254981
    [No Abstract] [Full Text] [Related]

  • 10. Treatment of Paget's disease with fluoride.
    Riggs BL, Jowsey J.
    Semin Drug Treat; 1972 Apr 25; 2(1):65-8. PubMed ID: 4558758
    [No Abstract] [Full Text] [Related]

  • 11. Determinants of remission of Paget's disease of bone.
    Patel S, Stone MD, Coupland C, Hosking DJ.
    J Bone Miner Res; 1993 Dec 25; 8(12):1467-73. PubMed ID: 8304048
    [Abstract] [Full Text] [Related]

  • 12. Treatment of Paget's disease with a diphosphonate (sodium etidronate).
    Smith R, Russell RG.
    Semin Drug Treat; 1972 Dec 25; 2(1):77-81. PubMed ID: 4558759
    [No Abstract] [Full Text] [Related]

  • 13. [Treatment of Paget's disease of bone with ethane-1 hydroxy-1, 1 diphosphonate at low dosage (author's transl)].
    Alexandre C, Chapuy MC, Bressot C, Vignon E, Arlot M, Mathieu L, Edouard C, Johnston CC, Meunier PJ.
    Nouv Presse Med; 1980 Nov 29; 9(45):3429-33. PubMed ID: 6777752
    [Abstract] [Full Text] [Related]

  • 14. Treatment of Paget's bone disease with the bisphosphonate APD.
    Mautalen CA.
    Henry Ford Hosp Med J; 1983 Nov 29; 31(4):244-8. PubMed ID: 6425243
    [No Abstract] [Full Text] [Related]

  • 15. Metabolic balance studies in patients with Paget's disease receiving salmon calcitonin over long periods.
    Oreopoulos DG, Husdan H, Harrison J, Meema HE, McNeill KG, Murray TM, Ogilvie R, Rapoport A.
    Can Med Assoc J; 1977 Apr 23; 116(8):851-5. PubMed ID: 856428
    [Abstract] [Full Text] [Related]

  • 16. Measurement of skeletal blood flow in normal man and in patients with Paget's disease of bone.
    Wootton R, Reeve J, Veall N.
    Calcif Tissue Res; 1976 Aug 23; 21 Suppl():380-5. PubMed ID: 782666
    [No Abstract] [Full Text] [Related]

  • 17. Salmon and porcine calcitonin treatment of Paget's disease of bone.
    Avramides A.
    Clin Orthop Relat Res; 1977 Aug 23; (127):78-85. PubMed ID: 303164
    [No Abstract] [Full Text] [Related]

  • 18. [Studies of variations in several biological parameters in Paget's disease (phosphatases, hydroxyproline...) before and after treatment with aspirin].
    Galmiche P, Lévy P.
    Rev Rhum Mal Osteoartic; 1967 Apr 23; 34(4):185-92. PubMed ID: 6059924
    [No Abstract] [Full Text] [Related]

  • 19. Metabolic effects of synthetic salmon calcitonin in Paget's disease of bone.
    Avramides A, Baker RK, Wallach S.
    Metabolism; 1974 Nov 23; 23(11):1037-46. PubMed ID: 4472557
    [No Abstract] [Full Text] [Related]

  • 20. Effects of calcitonin in Paget's disease and polyostotic fibrous dysplasia.
    Bell NH, Avery S, Johnston CC.
    J Clin Endocrinol Metab; 1970 Sep 23; 31(3):283-90. PubMed ID: 4916538
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.